版本:
中国

BRIEF-GSK files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with COPD

Nov 21 Glaxosmithkline Plc :

* GSK files regulatory submission in us for once-daily closed triple combination therapy ff/umec/vi for patients with copd Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐